Ancient foot massage technique may ease cancer symptoms
(Medical Xpress)—A study led by a Michigan State University researcher offers the strongest evidence yet that reflexology – a type of specialized foot massage practiced since the age of pharaohs – can ...
Cancer
Nov 13, 2012 |
5 / 5 (1) |
0
New developments reveal a molecule with a promising function in terms of cancer treatment.
Researchers from Inserm and CNRS from the Institute for genetics and molecular and cellular biology (IGBMC) and from the Research Institute at the Strasbourg school of biotechnology (Irebs) have focussed their efforts on ...
Cancer
Oct 30, 2012 |
5 / 5 (1) |
0
|
Only 5 percent of prostate cancer websites written below high school reading level, study finds
Ninety million American adults read below high school levels, so the National Institutes of Health recommends that patient-education materials be written at the fourth-through-sixth grade level.
Cancer
Oct 29, 2012 |
not rated yet |
0
Many terminal cancer patients put false hope in chemo, study finds
(HealthDay)—Many people with incurable cancer mistakenly believe chemotherapy may save them, a new study finds.
Cancer
Oct 24, 2012 |
not rated yet |
2
Chinese herbs show promise for lung cancer, flu, and idiopathic pulmonary fibrosis
Chinese herbs, including JHQG, BFXL, and BFHX, may show significant benefits for patients with non-small cell lung cancer (NSCLC), idiopathic pulmonary fibrosis (IPF), and influenza.
Medications
Oct 22, 2012 |
not rated yet |
0
Satiation hormone, neurotensin, linked to increased risk of disease, premature death in women
Researchers in Sweden have discovered that neurotensin, a satiation hormone produced in the human brain and intestine that circulates in the blood, could raise the risk of heart attack, breast cancer and ...
Medical research
Oct 19, 2012 |
not rated yet |
0
Patient-reported outcomes essential to comparative effectiveness research
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
Cancer
Oct 16, 2012 |
not rated yet |
0
Study shows fit elderly patients should be considered for therapy
Until there are more validated biomarkers to direct treatment decisions, many physicians use patient age to decide what therapy to give their patients. Literature data report that older patients often go undertreated because ...
Cancer
Oct 15, 2012 |
not rated yet |
0
Interventions helpful for breast cancer-induced menopause
(HealthDay)—Cognitive behavioral therapy (CBT) and physical exercise improve endocrine and urinary symptoms as well as physical functioning in patients with breast cancer treatment-induced menopause, according ...
Cancer
Oct 11, 2012 |
not rated yet |
0
New research looks to reduce animal testing for drug development
Researchers from Royal Holloway, University of London are looking at ways of testing the side effects of new drugs without using animals.
Medical research
Oct 10, 2012 |
5 / 5 (1) |
0
Simple meditation shown to decrease symptoms of stress and depression
A simple form of mindful meditation can help breast cancer survivors stave off the symptoms of depression, new research suggests. But the potential benefits don't stop there.
Psychology & Psychiatry
Oct 07, 2012 |
5 / 5 (4) |
0
Duplex-sequencing method could lead to better cancer detection and treatment
(Medical Xpress)—During an ice climbing trip to the Canadian Rockies last Christmas, two young researchers from the UW, Michael Schmitt and Jesse Salk, talked about a simple but powerful idea to get ...
Cancer
Oct 01, 2012 |
5 / 5 (1) |
0
|
Combination of targeted treatment drugs delays resistance in melanoma patients
Combined treatment with two drugs targeting different points in the same growth-factor pathway delayed the development of treatment resistance in patients with BRAF-positive metastatic malignant melanoma. The results of a ...
Cancer
Sep 29, 2012 |
not rated yet |
0
Clinical trial evaluates synthetic cannabinoid as brain cancer treatment
(Medical Xpress)—Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous ...
Cancer
Sep 26, 2012 |
not rated yet |
0
Researchers seek to understand brain's immune response to metastasized cancer
Brain metastases are common secondary complications of other types of cancer, particularly lung, breast and skin cancer. The body's own immune response in the brain is rendered powerless in the fight against ...
Cancer
Sep 25, 2012 |
not rated yet |
0
